Minimizing the environmental impact of our operations is essential to promoting healthy communities that thrive on a clean and sustainable planet.
Catalent is committed to reducing its environmental footprint in the following areas:
- Reducing CO₂ emissions linked to energy use at manufacturing sites by 15% over a five-year cycle
- Reducing hazardous and non-hazardous waste generation
- Responsibly managing water use and water quality, particularly as it relates to residual Active Pharmaceutical Ingredients (APIs) in waste water from manufacturing operations
Our approach to environmental management
Our Standards of Business Conduct commit Catalent to minimize our impact on the environment, complying with relevant laws, and operating with the required environmental permits, approvals, and controls.
Our Environmental Health and Safety (EHS) culture helps to integrate environmental responsibility and sustainability into management practices at our global facilities. The EHS Policy, signed by our President and COO, outlines our company-wide environmental stewardship objectives and commitments, and our expectations for employees to comply.
In fiscal 2019, we achieved global ISO14001 accreditation at 24 of Catalent’s main manufacturing facilities, validating the quality and reliability of our environmental management system. We aim to achieve accreditation for all 33 manufacturing sites over the next few years, including five of our most recently acquired sites.
Reducing our carbon footprint
As a science-based company, we are concerned about climate change and its potential impact on human health and the environment. We are committed to operating responsibly and to meeting our goal to reduce Catalent’s carbon emissions by 15% over five years.
In fiscal 2019, we strengthened our environmental data collection processes to provide a more precise measurement of Catalent’s carbon footprint and establish a baseline for future comparison. Our carbon reduction target and strategy will primarily focus on increasing energy efficiency at our sites and implementing renewable energy initiatives. Our energy management program is in broad alignment with the ISO50001:2018 energy management standard.
Most of our energy consumption, waste generation, and water use take place at our manufacturing sites. We are actively implementing programs and projects to reduce the environmental impact of these sites.
Our sites report environmental data through a central platform and our sustainability progress is tracked with an internal sustainability scorecard. The data guides our environmental strategy and helps our sites improve operational best practices and minimize our footprint on the planet.
Scope 2 CO₂ emissions linked to purchased energy use in operations make up the largest portion of our operational carbon footprint.
|CATEGORY||Column 3||Column 4|
|ENERGY USE (THOUSANDS MWH)|
|EMISSIONS (THOUSANDS MT CO₂ e)|
|ENERGY INTENSITY (MWh / $M REVENUE)|
1 Data represents energy, emissions and revenue from 30 Catalent manufacturing sites. Data does not include sites acquired in fiscal 2019. Estimates were used where actual data was not available.
2 Data includes electricity and natural gas use.
3 Data represents MWh of energy use per million dollars revenue generated by 30 Catalent manufacturing sites and includes inter-company revenue.
4 Catalent’s carbon footprint calculation was developed using the Greenhouse Gas Protocol. Our carbon emissions conversions from energy usage data available are based on International Energy Agency and Environmental Protection Agency conversion factors.
We aim to reduce our water footprint through conservation and efficiency measures. To become more efficient with our usage and minimize our water consumption, we are optimizing our operational and cleaning processes. Our sites meet or exceed local regulatory requirements for wastewater discharge.
|CATEGORY||Column 3||Column 4|
|WATER USE (MILLIONS M3)|
1 Data represents water use at 30 Catalent manufacturing sites. Data does not include sites acquired in fiscal 2019. Estimates were used where actual data was not available.
Minimizing active pharmaceutical ingredients (APIs) in wastewater
Responsibly disposing of residual API in wastewater is a critical issue for the pharmaceutical and biotech sectors. Some of the materials used to produce drugs and treatments can harm the environment if released into the ecosystem through wastewater. We take a risk-based approach to minimizing API in wastewater, focusing our efforts on our Softgel & Oral Technologies (SOT) and Oral & Specialty Drug Delivery (OSD) sites, where the risk is the greater due to the APIs handled and type of manufacturing processes we employ.
Following the most recent review of API in wastewater, we have identified the key sites in our network to invest in additional treatment options, including UV-sequestration, which renders eco-toxic API molecules to less harmful materials.
Improving waste management
We reduce our waste impact by eliminating the need to send non-hazardous waste to landfills and by managing hazardous waste responsibly. Our approach, aligned with regulatory requirements and ISO14001, requires sites to monitor waste and to implement an elimination or minimization plan. Every Catalent site collects and incinerates hazardous waste, including product-contaminated waste.
|CATEGORY||Column 3||Column 4|
|NON-HAZARDOUS WASTE GENERATION|
|HAZARDOUS WASTE GENERATION|
1 Data represents waste generation at 30 Catalent manufacturing sites. Data does not include sites acquired in fiscal 2019. Estimates were used where actual data was not available.
- Expanding programs to divert discarded personal protective equipment from landfill, including nitrile gloves
- Reviewing opportunities to increase the amount of excess gelatin that we recycle or reuse
- Piloting returnable packaging with a major clinical supply customer.
ENVIRONMENTAL IMPACT OF OUR SUPPLY CHAIN
We are an active member of the Pharmaceutical Supply Chain Initiative (PSCI), a group of companies from the healthcare and pharmaceutical sector dedicated to improving the industry’s social and environmental impacts. Since joining the initiative in 2016, we have collaborated with suppliers, customers, and competitors to drive responsible supply chain management and increased transparency across the pharmaceutical sector.
Employees, such as this team participating in a beach clean-up in St. Petersburg, FL, are a key driver of our corporate responsibility & sustainability strategy. Greens teams, local groups of employees that organize environmental actions at our sites and in our communities, are sprouting up across the network.